Legal & General Group PLC Immunovant, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 57,682 shares of IMVT stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,682

Previous 53,266 8.29%

Holding current value

$1.59 Million

Previous $1.72 Million 11.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $110,841 - $139,589	4,416 Added 8.29%	57,682 $1.52 Million
Q1 2024 May 14, 2024	SELL	$30.27 - $43.79 $6,719 - $9,721	-222 Reduced 0.42%	53,266 $1.72 Million
Q4 2023 Feb 15, 2024	SELL	$31.31 - $44.19 $182,224 - $257,185	-5,820 Reduced 9.81%	53,488 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $158,231 - $340,858	8,530 Added 16.8%	59,308 $2.28 Million
Q2 2023 Aug 14, 2023	BUY	$14.2 - $23.75 $507,110 - $848,160	35,712 Added 237.04%	50,778 $963,000
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $13,239 - $17,097	867 Added 6.11%	15,066 $233,000
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $58,399 - $94,658	-14,860 Reduced 51.14%	14,199 $80,000
Q2 2022 Aug 22, 2022	SELL	$3.38 - $5.65 $2,619 - $4,378	-775 Reduced 2.6%	29,059 $113,000
Q1 2022 May 16, 2022	BUY	$5.06 - $8.77 $713 - $1,236	141 Added 0.47%	29,834 $164,000
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $11,999 - $15,256	1,637 Added 5.83%	29,693 $253,000
Q3 2021 Nov 15, 2021	BUY	$7.01 - $11.37 $49,567 - $80,397	7,071 Added 33.7%	28,056 $244,000
Q2 2021 Aug 12, 2021	SELL	$9.4 - $16.85 $8,121 - $14,558	-864 Reduced 3.95%	20,985 $222,000
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $213,047 - $807,884	16,288 Added 292.9%	21,849 $351,000
Q4 2020 Feb 12, 2021	SELL	$36.36 - $52.71 $9,889 - $14,337	-272 Reduced 4.66%	5,561 $258,000
Q3 2020 Nov 13, 2020	BUY	$22.61 - $38.9 $38,097 - $65,546	1,685 Added 40.62%	5,833 $206,000
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $57,532 - $117,969	4,148 New	4,148 $101,000

Others Institutions Holding IMVT

# of Institutions

220

Shares Held

65.1M

Call Options Held

697K

Put Options Held

629K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Immunovant, Inc. Transaction History